Altre lingue Biogen Inc. Xetra

Azioni

IDP

US09062X1037

Mercato chiuso - Xetra Altri mercati azionari 17:35:46 05/07/2024			Variaz. 5gg	Var. 1 gen.
208,1 ^EUR	-0,10%		-3,30%	-11,37%

02/07	I mercati azionari statunitensi terminano in rialzo martedì dopo i commenti del presidente della Fed Powell	MT
02/07	I mercati azionari sono per lo più in rialzo durante la giornata dopo i commenti del presidente della Fed Powell	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BIIB Kessler Topaz Meltzer & Check, LLP Reminds Biogen Inc. (BIIB) Investors of Securities Fraud Class Action Lawsuit Filed On the Behalf	04/07
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen	03/07
July 22, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against BIIB	03/07
USA: feu vert au traitement d'Eli Lilly contre la maladie d'Alzheimer	03/07
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit	03/07
US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments	02/07
Equity Markets Mostly Rise Intraday After Fed Chair Powell's Comments	02/07
Eli Lilly Alzheimer's drug approved by US FDA	02/07
Biogen Inc. Sued for Securities Law Violations - Contact the Schall Law Firm to Discuss Your Legal Rights BIIB	02/07
Biogen Closes Human Immunology Biosciences Acquisition	02/07
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIB	02/07
Biogen Completes Acquisition of Human Immunology Biosciences	02/07
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc.(BIIB) Shareholders	01/07
Japan's Eisai developing dementia drug for US market, Nikkei reports	30/06
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Biogen Inc. (BIIB)	29/06
BIIB LAWSUIT ALERT: The Gross Law Firm Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	28/06
Biogen, Eisai Launch Leqembi in China to Treat Alzheimer's Disease	28/06
Eisai and Biogen launch Alzheimer's drug Leqembi in China	28/06
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China	28/06
Eisai Co., Ltd. and Biogen Inc. Announces Launch of Leqembi in China	28/06

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Biogen Inc. Xetra

Azioni

IDP

US09062X1037

Altre lingue

Filtri